✦ LIBER ✦

Design and evaluation of mixed self-assembled monolayers for a potential use in everolimus eluting coronary stents

✍ Scribed by Mirmohseni, Abdolreza; Hosseini, Javad; Shojaei, Maryam; Davaran, Soodabeh

Book ID: 120837334
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 790 KB
Volume: 112
Category: Article
ISSN: 0927-7765
DOI: 10.1016/j.colsurfb.2013.07.069

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interaction of endothelial cells with se

Interaction of endothelial cells with self-assembled monolayers for potential use in drug-eluting coronary stents

✍ Gopinath Mani; Bysani Chandrasekar; Marc D. Feldman; Devang Patel; C. Mauli Agra 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 952 KB

## Abstract Drug‐eluting stents (DES) are implanted in patients to treat in‐stent restenosis. Commercially available DES use polymers for coating and releasing drugs. Several studies have showed that polymer coatings cause adverse reactions. Delayed endothelialization of polymer‐coated DES leads to

The use of alkanethiol self-assembled mo

The use of alkanethiol self-assembled monolayers on 316L stainless steel for coronary artery stent nanomedicine applications: an oxidative and in vitro stability study

✍ Anil Mahapatro; Dave M. Johnson; Devang N. Patel; Marc D. Feldman; Arturo A. Ayo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 675 KB

ABSORB II randomized controlled trial: A

ABSORB II randomized controlled trial: A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design

✍ Roberto Diletti; Patrick W. Serruys; Vasim Farooq; Krishnankutty Sudhir; Cecile 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 419 KB

Amsterdam Investigator–initiateD Absorb

Amsterdam Investigator–initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design

✍ Woudstra, Pier; Grundeken, Maik J.; Kraak, Robin P.; Hassell, Mariëlla E.C.J.; A 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 813 KB

9-Month Clinical, Angiographic, and Intr

9-Month Clinical, Angiographic, and Intravascular Ultrasound Results of a Prospective Evaluation of the Axxess Self-Expanding Biolimus A9-Eluting Stent in Coronary Bifurcation Lesions: The DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) Study

✍ Stefan Verheye; Pierfrancesco Agostoni; Christophe L. Dubois; Joseph Dens; John 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 518 KB

A 2 × 2 Factorial Design Rando

A 2 × 2 Factorial Design Randomised Control Trial Assessing the Efficacy of High Pressure Coronary Stent Deployment and Post-dilation to Achieve Relative Oversize Compared to Nominal Stent Deployment and Sizing in Patients at High Risk for Re-stenosis Using the Endeavor Drug-eluting Stent Versus Bare Metal Stents: The HEADROOM trial—Report of the First 100 Patients

✍ Joseph Matthews; Mark Pitney; Nigel Jepson; Robert Giles; Daniel Friedman; Roger 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 84 KB